In the multivariate analysis use of co-medication remained associated with ADE (p<0.001) (), while age and chronic disease were not.10.1371/journal.pone.0051860.g003 Figure 3: Percentage of adverse drug events with number of co-medication per age category during 2000-2009.. #caption-ended-head#00003#.
